Inmito Meditech Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 2.30 M
- Company Age 14 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.95 M
- Revenue Growth %
- Ebitda
- Net Worth 9.90%
- Total Assets 6.58%
About Inmito Meditech
Inmito Meditech Private Limited (IMPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 July 2010 and has a history of 14 years and seven months. Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.30 M.
The company currently has active open charges totaling ₹8.95 M.
Naveen Khanna and Vipin Tyagi serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U33110DL2010PTC205198
- Company No.
205198
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jul 2010
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Inmito Meditech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naveen Khanna  | Director | 03-Jul-2010 | Current |
| Vipin Tyagi | Director | 03-Jul-2010 | Current |
Financial Performance of Inmito Meditech.
Inmito Meditech Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth moved up by a moderate rise of 9.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Inmito Meditech?
In 2020, Inmito Meditech had a promoter holding of 78.26% and a public holding of 21.74%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Inmito Healthtech Private LimitedNaveen Khanna and Vipin Tyagi are mutual person
Charges (Loans)
₹8.95 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.89 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Jul 2014 | Hdfc Bank Limited | ₹8.95 M | Open |
How Many Employees Work at Inmito Meditech?
Unlock and access historical data on people associated with Inmito Meditech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Inmito Meditech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inmito Meditech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.